Ropivacaine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00296 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 4 | dysthymic disorder | KG + DL |
| 5 | fibromyalgia | KG + DL |
| 6 | myofascial pain syndrome | KG + DL |
| 7 | tendinitis | KG + DL |
| 8 | myositis fibrosa | KG + DL |
| 9 | idiopathic granulomatous myositis | KG + DL |
| 10 | bronchitis | KG + DL |
| 11 | methemoglobinemia | KG + DL |
| 12 | atrophoderma vermiculata | KG + DL |
| 13 | headache disorder | KG + DL |
| 14 | Tourette syndrome | KG + DL |
| 15 | migraine with or without aura, susceptibility to | KG + DL |
| 16 | inclusion body myositis | KG + DL |
| 17 | ulerythema ophryogenesis | KG + DL |
| 18 | obsessive-compulsive disorder | KG + DL |
| 19 | trigeminal autonomic cephalalgia | KG + DL |
| 20 | vestibular neuronitis | KG + DL |
| 21 | brachial plexus neuritis | KG + DL |
| 22 | motor nerve neuritis | KG + DL |
| 23 | methemoglobinemia, alpha type | KG + DL |
| 24 | neuroretinitis | KG + DL |
| 25 | trichotillomania | KG + DL |
| 26 | histrionic personality disorder (disease) | KG + DL |
| 27 | paranoid personality disorder | KG + DL |
| 28 | schizoid personality disorder | KG + DL |
| 29 | schizotypal personality disorder | KG + DL |
| 30 | rheumatoid arthritis | KG + DL |
| 31 | methemoglobin reductase deficiency | KG + DL |
| 32 | sciatic neuropathy | KG + DL |
| 33 | conjunctivitis | KG + DL |
| 34 | rhinitis | KG + DL |
| 35 | anxiety disorder | KG + DL |
| 36 | neurotic disorder | KG + DL |
| 37 | nephrogenic diabetes insipidus-intracranial calcification syndrome | KG + DL |
| 38 | methemoglobinemia due to deficiency of methemoglobin reductase | KG + DL |
| 39 | major depressive disorder | KG + DL |
| 40 | gout | KG + DL |
| 41 | pulmonary hypertension | KG + DL |
| 42 | nephrogenic diabetes insipidus | KG + DL |
| 43 | Ohdo syndrome and variants | KG + DL |
| 44 | exostosis | KG + DL |
| 45 | trigeminal nerve neoplasm | KG + DL |
| 46 | neurotic depression | KG + DL |
| 47 | melancholia | KG + DL |
| 48 | obsolete vascular headache | KG + DL |
| 49 | agoraphobia | KG + DL |
| 50 | infectious otitis media | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.